ArticleInternational journal of hypertension2022
A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients with Essential Hypertension and Type 2 Diabetes in Asia.
Chaicharn Deerochanawong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.